Read + Share
Amedeo Smart
Independent Medical Education
Mohebbi A, Shahriyary F, Farrokhi V, Bandar B, et al. A systematic review of second-generation FLT3 inhibitors for treatment of patients with relapsed/refractory acute myeloid leukemia. Leuk Res 2024;141:107505.PMID: 38692232
Email
LinkedIn
Privacy Policy